Skip to main content

Table 8 Significantly higher expressed genes in CD56+ compared to CD56– SMDC

From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence

Gene

CD56+ SMDC

CD56– SMDC

Log2 fold change

KBTBD10

10.64

3.61

7.11

CHRNA1

12.42

6.64

5.77

TTN

10.81

5.37

5.63

ALDH1A1

10.84

5.24

5.52

COL14A1

10.71

5.69

5.36

CASQ2

9.09

4.60

5.29

F13A1

10.54

5.44

5.24

NEB

10.06

5.21

5.02

MEGF10

10.83

5.99

4.85

PDLIM3

10.95

6.13

4.85

STAC3

10.06

5.27

4.78

OLFML2A

11.19

6.53

4.77

MYL1

10.48

6.30

4.76

NCAM1

10.03

5.42

4.75

DES

10.92

6.13

4.75

KCNN3

9.95

5.56

4.57

SMYD1

8.52

4.66

4.51

CHRNG

10.18

5.84

4.46

TRIM55

8.94

4.68

4.42

TMEM8C

9.92

6.10

4.30

LRRN1

9.18

5.47

4.03

DLL1

9.63

5.84

4.01

ACTA1

10.01

6.46

4.00

ITGB6

8.37

4.54

3.99

METTL7B

10.01

6.02

3.99

ITGA8

8.86

4.87

3.99

ASB5

8.45

4.60

3.97

MYOG

10.27

6.58

3.93

FABP3

9.68

5.94

3.92

PRUNE2

9.31

5.47

3.84

CHST15

10.93

7.11

3.82

TNNT1

9.61

5.92

3.82

SGCA

10.66

6.93

3.75

ITGA7

10.14

6.38

3.75

RUNX1IT1

8.98

5.23

3.75

MYBPH

9.77

6.08

3.74

FAM49A

10.19

6.56

3.68

GABRB2

8.38

5.04

3.67

CDON

9.53

5.89

3.66

NRCAM

7.74

4.73

3.58

TPPP3

10.23

6.67

3.57

RCAN2

10.26

6.71

3.55

MUSK

8.33

4.86

3.54

L1CAM

9.04

5.49

3.54

MYF5

8.51

5.37

3.54

MYOD1

9.83

6.30

3.53

TTC9

9.81

6.29

3.53

VCAM1

8.40

4.98

3.49

CHRNB1

9.92

6.58

3.47

DCLK1

9.38

6.08

3.43

DYSF

8.96

5.74

3.41

HSPB3

7.91

4.89

3.39

RAPSN

10.17

6.86

3.36

MURC

8.90

5.62

3.31

GPRC5B

8.99

6.07

3.29

SYNPO2L

8.65

5.54

3.28

KIAA1244

9.30

6.37

3.26

ALPK3

8.99

5.75

3.25

ACTN2

8.02

5.20

3.20

PCDH7

8.78

5.60

3.19

MYLPF

10.04

7.05

3.19

LMOD3

7.26

4.50

3.15

CDH15

9.30

6.20

3.09

EYA1

7.72

4.73

3.08

FGFR4

8.45

5.57

3.03

TXLNB

7.97

5.03

3.01

PCDHB14

9.59

6.62

2.99

NEDD4L

9.32

6.34

2.99

MIR27B

8.05

5.10

2.98

GATM

8.19

5.35

2.98

PALMD

9.78

6.82

2.97

MEF2C

7.89

5.04

2.96

DAPK1

7.81

5.00

2.96

A2M

8.91

6.08

2.91

ZIC1

7.66

4.76

2.89

SCN5A

8.40

5.51

2.89

ANKRD29

9.15

6.40

2.82

ZNF608

8.34

5.54

2.81

SAMD5

8.39

5.67

2.81

SLC12A7

9.24

6.70

2.78

PCDHB5

8.62

5.86

2.78

IGFBPL1

8.41

5.77

2.77

NPNT

7.33

4.86

2.75

RGS16

9.28

6.63

2.72

DES

9.48

6.79

2.70

GMPR

8.65

6.02

2.70

IL17RD

8.91

6.25

2.69

F11R

8.57

5.92

2.65

MYPN

8.53

5.99

2.64

FMNL1

8.89

6.35

2.57

ST8SIA5

7.90

5.37

2.57

LAMA3

8.37

5.83

2.57

C1orf187

8.49

5.97

2.57

TSPAN15

8.08

5.50

2.56

PAX7

8.37

6.03

2.51

DBHAS1

8.10

5.60

2.50

FGL2

8.77

6.32

2.50

DMBT1

7.80

5.28

2.48

JUP

9.49

7.01

2.46

JAM2

8.36

5.93

2.45

PNPLA3

8.42

5.94

2.45

TNS3

8.92

6.53

2.39

CLSTN2

8.88

6.48

2.38

PCDH19

8.75

6.49

2.37

FGF11

8.92

6.59

2.36

VAMP8

8.40

6.07

2.33

ST8SIA2

8.05

5.75

2.31

PCDHB15

7.46

5.16

2.30

TUBA3FP

8.18

5.88

2.30

LAMA5

9.24

7.01

2.27

SYTL2

8.87

6.64

2.24

ECM2

8.33

6.08

2.24

ITPR1

8.37

6.17

2.24

GAS1

9.46

7.28

2.18

HOXA2

8.02

5.88

2.18

PM20D2

7.87

5.76

2.11

SPRY1

7.45

5.42

2.07

PKNOX2

8.21

6.17

2.07

WNT9A

8.93

6.87

2.07

TRIM72

8.61

6.60

2.05

SIX1

7.69

5.64

2.05

SLC40A1

7.89

5.89

2.03

PCDHB12

7.42

5.40

2.02

GPR153

9.30

7.31

2.02

PCDHB16

7.33

5.37

1.96

PCDHB3

7.64

5.70

1.93

PCDHB9//PCDHB10

8.25

6.35

1.89

TOX

9.11

7.23

1.88

CFI

7.39

5.53

1.86

HEYL

7.95

6.14

1.86

BOC

8.98

7.15

1.84

TMEM150C

7.91

6.07

1.83

WBSCR17

7.41

5.65

1.79

SHISA2

7.69

5.90

1.78

PAX3

7.49

5.73

1.77

PPFIA4

8.49

6.72

1.77

AR

8.06

6.30

1.76

SERPING1

8.21

6.47

1.76

TSPAN9

8.23

6.49

1.73

BMP4

7.29

5.58

1.72

MTSS1

8.25

6.60

1.67

DTNA

7.48

5.83

1.66

TMEM86A

7.40

5.78

1.63

DUSP13

8.04

6.43

1.62

C1orf38

8.01

6.44

1.57

KY

8.38

6.83

1.56

LAPTM5

8.50

6.97

1.53

SYTL3

8.34

6.86

1.48

PCDHB2

7.55

6.10

1.45

KIAA1549

8.70

7.27

1.44